84 related articles for article (PubMed ID: 7579728)
1. Retinoblastoma gene mutation in primary human renal cell carcinoma.
Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation in primary human renal cell carcinoma.
Torigoe S; Shuin T; Kubota Y; Horikoshi T; Danenberg K; Danenberg PV
Oncol Res; 1992; 4(11-12):467-72. PubMed ID: 1299377
[TBL] [Abstract][Full Text] [Related]
3. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
4. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing.
Hogg A; Onadim Z; Baird PN; Cowell JK
Oncogene; 1992 Jul; 7(7):1445-51. PubMed ID: 1352398
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
9. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.
Claudio PP; Howard CM; Fu Y; Cinti C; Califano L; Micheli P; Mercer EW; Caputi M; Giordano A
Cancer Res; 2000 Jan; 60(1):8-12. PubMed ID: 10646842
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma.
Kato MV; Ishizaki K; Toguchida J; Kaneko A; Takayama J; Tanooka H; Kato T; Shimizu T; Sasaki MS
Hum Mutat; 1994; 3(1):44-51. PubMed ID: 8118465
[TBL] [Abstract][Full Text] [Related]
14. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase beta gene mutations in human bladder cancer.
Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
[TBL] [Abstract][Full Text] [Related]
16. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung.
Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602
[TBL] [Abstract][Full Text] [Related]
17. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Jpn J Clin Oncol; 1995 Oct; 25(5):173-8. PubMed ID: 7474403
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
Oda H; Nakatsuru Y; Ishikawa T
Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
[TBL] [Abstract][Full Text] [Related]
19. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
20. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]